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RETINOIC ACID SYNDROME - RADIOLOGICAL FEATURES 
The treatment of acute promyelocytic leukemia (APL) with all- 
trans-retinoic acid (ATRA) sometimes results in a syndrome 
characterized by fever, respiratory distress, pleural and pericar- 
dial effusion, weight gain, and pulmonary infiltrates on chest 
radiography (2). We have recently observed a patient with radi- 
ological features suggesting the diagnosis of retinoic acid syn- 
drome, which to our knowledge has not earlier been mentioned 
in the radiological literature. 
The patient was a 23-year-old woman presenting with fever 
and pancytopenia. She was diagnosed as having APL and was 
treated with ATRA. On the fifth day of therapy, she became 
acutely short of breath. Her respiratory rate was accelerated, her 
pulse rate was 160/min, temperature 3 7 T ,  and blood pressure 
140/80 mm Hg. Auscultation of the chest revealed diminished 
breath sounds on the left side. A chest radiograph showed alve- 
olar infiltrates on the right side and opacification of the left 
hemithorax due to pleural effusion. Analysis of arterial blood 
gases revealed marked hypoxemia. She was managed with 
mechanical ventilation and 10 mg of dexamethasone twice 
daily. A left-sided chest tube was placed for draining off hemor- 
rhagic fluid, with diminution of the pleural effusion. Alveolar 
infiltrates persisted at the right lung base. The clinical and radi- 
ological signs further improved and there was complete resolu- 
tion of the pulmonary infiltrates and the effusion by the third 
week. 
ATRA is a normal constituent of plasma. It is probably 
derived physiologically by intracellular oxidation of plasma 
retinol that has been absorbed from the intestines (1, 7). When 
administered in therapeutic doses it produces the differentiation 
of immature neoplastic cells into mature granulocytes (4). Com- 
pared with most anitcancer drugs used for treating acute APL, 
ATRA is considered highly safe. 
However, the retinoic acid syndrome develops in approxi- 
mately 25% of patients (2). It may occur between the second 
day and the third week of treatment. Death may occur from pro- 
gressive hypoxemia and multiorgan failure. Patients with APL 
who present with a high tumor burden or develop leukocytosis 
are more likely to suffer from this syndrome (7). Clinically the 
situation resembles the capillary leak syndrome, which results 
after infusion of cytokines, i.e. interleukin-2 (5). An explanation 
as to the pathogenesis is that the drug induces functional matu- 
ration and migratory capacity in undifferentiated leukemic cells. 
The migration of these cells into the lung tissue could explain 
the respiratory distress (3). Autopsy has displayed extensive 
infiltration of myeloid cells in the lung, liver, skin and kidneys 
(2). Recently it has been found that ATRA upregulates the 
integrin gene on leukocytes which enhances their adherence to 
the capillary endothelium and promotes focal endothelial leak- 
age (2,6). 
The syndrome is difficult to manage once established. 
Hence, early recognition of the syndrome is important. Unex- 
plained dyspnea, weight gain and fever are good indicators. The 
radiographic abnormalities are nonspecific and resemble pul- 
monary edema or infection. The sudden appearance of pleural 
effusion may indicate the onset of this ominous condition. 
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